Sreeji Gopinathan joins Lupin as Chief Information Officer Medical Dialogues Bureau3 Oct 2019 4:03 PM ISTMumbai, October 03, 2019: Pharma major Lupin Limited announced today the appointment of Sreeji Gopinathan as Chief Information Officer (CIO). He will...
Biocon, Mylan launch insulin biosimilar Semglee in Australia Medical Dialogues Bureau3 Oct 2019 3:51 PM ISTNew Delhi: Biotechnology major Biocon and pharmaceutical company Mylan N V on Thursday announced the launch of their insulin biosimilar Semglee,...
PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply Medical Dialogues Bureau30 Sept 2019 5:54 PM ISTIt was submitted that notifying blood monitoring devices, digital thermometers, nebulizers and glucometers as DRUGS will result in a substantial hike...
Definition of generic drugs discussed in Parliament Farhat Nasim7 July 2019 9:50 AM ISTHe said that the generic medicines are generally those which contain some amount of same active ingredients in same dosage form, and are intended to...
Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft Farhat Nasim28 Jun 2019 4:44 PM ISTNew Delhi: Through a recent draft Gazette notification, the Ministry of Health and Family Welfare has informed that not just drugmakers but drug...
Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director Farhat Nasim16 Jun 2019 9:31 AM ISTSanjay Murdeshwar is Country President, Novartis in India and responsible for the company's pharmaceuticals business in the country.New Delhi: Pharma...
Yes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 crore Farhat Nasim12 Jun 2019 11:29 AM ISTNew Delhi: Yes Bank has reduced its stake in Fortis healthcare (FHL) by around 2 per cent by selling over 1.51 crore shares of the company in various...
Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC Medical Dialogues Bureau9 Jun 2019 11:15 AM ISTThe commission also said in its view, diabetes was a lifestyle disease in India and the whole insurance claim (Mediclaim) cannot be rejected only...
Natco Pharma- Kothur facility gets 9 observations from USFDA Medical Dialogues Bureau7 Jun 2019 2:21 PM ISTNEW DELHI: Natco Pharma Thursday said the US health regulator has made nine observations after the completion of inspection of its Kothur formulation...
Healthcare Startup Pristyn Care raises Rs 27 crore funding from Sequoia India Medical Dialogues Bureau5 Jun 2019 2:36 PM ISTNew Delhi: Healthcare delivery startup Pristyn Care Monday said it has raised USD 4 million (about Rs 27.7 crore) in funding from Sequoia...
Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis Medical Dialogues Bureau1 Jun 2019 2:39 PM ISTNew Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 5:12 PM ISTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
